Client login

Pharmaceutical Development / Overcoming the analytical method development hurdles associated with pediatric solid dosage forms

Article

Back

Overcoming the analytical method development hurdles associated with pediatric solid dosage forms

Developing analytical methods for pediatric solid dose products presents unique challenges that differ significantly from those encountered with adult formulations, reports Chloe Watson, Analytical Technical Leader at Almac Pharma Services.

View Resource

Almac Pharmaceutical Drug Product Development

Addressing the increasing pressure on pharmaceutical companies to bring clinical candidates through their pipeline faster and with greater efficiency, Almac Pharma Services provide expert pharmaceutical drug product development solutions.

Our scientists can develop clinical candidates into optimum formulations and manufacture solid oral dose products for all stages of clinical trials.

From developing a fit-for-purpose formulation for First-in-Human trials, to scaling up for late phase trials.

Learn More